2YKL
Structure of human anti-nicotine Fab fragment in complex with nicotine-11-yl-methyl-(4-ethylamino-4-oxo)-butanoate
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ESRF BEAMLINE BM14 |
Synchrotron site | ESRF |
Beamline | BM14 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2010-05-06 |
Detector | MARMOSAIC 225 mm CCD |
Spacegroup name | C 1 2 1 |
Unit cell lengths | 74.240, 78.840, 73.690 |
Unit cell angles | 90.00, 116.10, 90.00 |
Refinement procedure
Resolution | 30.000 - 2.100 |
R-factor | 0.21658 |
Rwork | 0.214 |
R-free | 0.27404 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 2yk1 |
RMSD bond length | 0.010 |
RMSD bond angle | 1.212 |
Data reduction software | MOSFLM |
Data scaling software | SCALA |
Refinement software | REFMAC (5.5.0109) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 40.000 | 2.210 |
High resolution limit [Å] | 2.100 | 2.100 |
Rmerge | 0.060 | 0.280 |
Number of reflections | 22342 | |
<I/σ(I)> | 7.8 | 2 |
Completeness [%] | 100.0 | 100 |
Redundancy | 3.7 | 3.6 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 6.5 | SITTING DROP, 0.1 M SODIUM CACODYLATE PH 6.5, 0.2 M MGCL2, 31% PEG MME 2000, 10 MG/ML PROTEIN, 20MM NICOTINE-11-YL-METHYL-(4-ETHYLAMINO-4-OXO)-BUTANOATE. |